Boston Partners’s Covisint Corporation COVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-636,434
Closed -$1.3M 814
2017
Q1
$1.3M Sell
636,434
-169,180
-21% -$337K ﹤0.01% 690
2016
Q4
$1.53M Sell
805,614
-227,057
-22% -$490K ﹤0.01% 690
2016
Q3
$2.25M Buy
1,032,671
+1,079
+0.1% +$2.36K ﹤0.01% 645
2016
Q2
$2.25M Sell
1,031,592
-88,791
-8% -$172K ﹤0.01% 632
2016
Q1
$2.24M Buy
1,120,383
+69,933
+7% +$142K ﹤0.01% 598
2015
Q4
$2.63M Sell
1,050,450
-440,272
-30% -$997K ﹤0.01% 572
2015
Q3
$3.21M Buy
1,490,722
+37,230
+3% +$102K ﹤0.01% 553
2015
Q2
$4.75M Buy
1,453,492
+312,824
+27% +$741K 0.01% 517
2015
Q1
$2.32M Buy
1,140,668
+974,432
+586% +$2.27M ﹤0.01% 604
2014
Q4
$441K Buy
+166,236
New +$476K ﹤0.01% 697

Other funds holding COVS

Boston Partners's COVS Position: Q2 2017 in Review

Boston Partners sold out of Covisint Corporation (COVS) in Q2 2017, closing a stake of 636,434 shares — an estimated $1.3M sold.

Boston Partners first reported a position in COVS in Q4 2014 and held it in 10 quarters. The position peaked at $4.75M in Q2 2015. 70 funds tracked by Wall St. Rank hold COVS as of Q2 2017.

  • Boston Partners reported no remaining Covisint Corporation position as of Q2 2017 after selling out during the quarter.
  • Boston Partners sold 636,434 Covisint Corporation shares in Q2 2017, an estimated $1.3M.
  • Boston Partners first reported a position in Covisint Corporation in Q4 2014 and held it in 10 quarters.
  • Boston Partners's Covisint Corporation position peaked at $4.75M in Q2 2015.
  • 70 funds tracked by Wall St. Rank held Covisint Corporation as of Q2 2017.

Based on Boston Partners's 13F filing for Q2 2017, filed 2 Aug 2017.